RETRACTED: Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial.

J Clin Virol · 2022 · PMC9313533 · PMID 35952426

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This change reduced the number of subjects available for analysis for the primary endpoint from 648 to 556 but despite this the reduction in SARS-CoV-2 infection in the test group remained highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.